Home/Filings/4/0001415889-22-007687
4//SEC Filing

Smith Mark Alan 4

Accession 0001415889-22-007687

CIK 0001411685other

Filed

Jul 14, 8:00 PM ET

Accepted

Jul 15, 4:30 PM ET

Size

4.8 KB

Accession

0001415889-22-007687

Insider Transaction Report

Form 4
Period: 2022-06-30
Smith Mark Alan
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Common Stock

    2022-06-30$0.75/sh+5,000$3,74019,915 total
Footnotes (1)
  • [F1]Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)

Issuer

VistaGen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1
  • filerCIK 0001677452

Filing Metadata

Form type
4
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 4:30 PM ET
Size
4.8 KB